Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing
Kinder mit Diabetes und mindestens einem nicht-autoimmunen Merkmal sollten für eine Testung auf monogene Diabetesformen erwogen werden
The Journal of Clinical Endocrinology & Metabolism · 21.01.2026 · 111 (2) · e362-e367
DOI: 10.1210/clinem/dgaf430 ↗Auf einen Blick
Bei 183 Kindern mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal wurden bei 33 % monogene Diabetesformen gefunden. Islet-Antikörper und T1DGRS halfen bei der Priorisierung der Testung.
Fragestellung
Sollten bei Kindern mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal alle auf monogene Diabetesformen getestet werden?
Methode
183 Kinder mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal; Bestimmung von Islet-Antikörpern und T1DGRS; zielgerichtete Next-Generation-Sequenzierung aller bekannten Ursachen monogener Diabetesformen.
Ergebnisse
33 % (61/183) hatten bestätigten monogenen Diabetes. 84 % (51/61) waren rezessiv; häufig waren WFS1 (46 %), SLC19A2 (12 %) und SLC29A3 (12 %).
Schlussfolgerung der Autor:innen
Kinder mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal sollten für eine Testung auf monogene Diabetesformen erwogen werden. Islet-Antikörper und T1DGRS helfen, genetische Tests zu priorisieren.
Kernaussagen
- 33 % (61/183) hatten bestätigten monogenen Diabetes
- 84 % der monogenen Fälle hatten rezessive Ursachen
- Islet-Antikörper und T1DGRS halfen bei der Priorisierung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.08.2025. Verfasst von Rebecca Myers und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical and Clinical Science, University of Exeter, Exeter EX2 5DW, UK. Hauptthemen laut MEDLINE: Genetic Testing, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Diabetes UK, Wellcome Trust Senior Investigator.
Themen: Diabetes mellitus, Kinderkrankenpflege
Abstract (Originalsprache)
Context
Monogenic diabetes testing in children currently targets maturity onset diabetes in the young (MODY) or recognized genetic syndromes.
Objective
We aim to determine whether genetic testing for monogenic diabetes should be performed for all children with diabetes and at least one non-autoimmune extra-pancreatic feature (syndromic diabetes).
Methods
We recruited 183 children with diabetes and at least one non-autoimmune extra-pancreatic feature (50% [n = 91] with self-reported consanguinity). We measured islet-autoantibodies and type 1 diabetes (T1D) genetic risk score (T1DGRS) and used targeted next-generation sequencing to analyze all known causes of monogenic diabetes.
Results
Of the children, 33% (61/183) had confirmed monogenic diabetes. Of these, 84% (51/61) had recessive etiologies with variants in WFS1 (46%), SLC19A2 (12%) and SLC29A3 (12%) being most common. Monogenic cases compared to non-monogenic had similar age of diagnosis (7.4 vs 6, P = .1) and body mass index z-score (−0.08 vs −0.41, P = .3) but had higher parental consanguinity (62% vs 19%, P = .01) and features in multiple organ systems (53% vs 28%, P = .01). Only 59% reported well-recognized features of their associated genetic syndrome. Children with low T1DGRS (<50th centile of T1D population) and negative/untested antibodies were more likely to have monogenic cause compared to positive antibodies or negative/untested antibodies and a high T1DGRS (≥ 50th centile) (48% vs 3% vs 7%, P < .0001).
Conclusion
Children with diabetes and at least one non-autoimmune extra-pancreatic feature should be considered for monogenic diabetes testing. Measurement of islet-autoantibodies and T1DGRS help prioritize genetic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical and Clinical Science, University of Exeter, Exeter EX2 5DW, UK.
- Department of Pediatric Endocrinology, Istanbul University Faculty of Medicine, 34093 Istanbul, Turkey.
- Department of Paediatric Endocrinology, Gazi Yasargil Diyarbakir Training and Research Hospital, 21100 Diyarbakir, Turkey.
- Department of Pediatric Endocrinology and Diabetes, Children's Hospital, University of Child Health Sciences, Lahore 54600, Pakistan.
- National Institute of Child Health, Paediatric Endocrinology and Diabetes Department, Karachi 75510, Pakistan.
- Department of Diabetes, King Edward Memorial Hospital & Research Centre, Pune 411011, India.
ORCID-Profile: Rebecca Myers, Melek Yildiz, Sezer Acar, Korcan Demir, Andrew Hattersley, Kashyap Patel
Förderung
- Wellcome Trust
- Diabetes UK
- Wellcome Trust Senior Investigator
Zitieren
APA
Myers, R., Yildiz, M., Nuri Ozbek, M., Manzoor, J., Ibrahim, M., Yajnik, C., Atar, M., Şiklar, Z., Acar, S., Globa, E., Magdy Omar, O., Demirbilek, H., Hassan, S., Demir, K., Hanif, M., Guran, T., Hatipoglu, N., Koçyiğit, C., Colclough, K., …, & Monogenic Diabetes Consortium (2026). Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing. The Journal of Clinical Endocrinology & Metabolism, 111(2), e362-e367. https://doi.org/10.1210/clinem/dgaf430
Vancouver
Myers R, Yildiz M, Nuri Ozbek M, Manzoor J, Ibrahim M, Yajnik C, et al. Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing. The Journal of Clinical Endocrinology & Metabolism. 2026;111(2):e362-e367. doi:10.1210/clinem/dgaf430
BibTeX
@article{Myers2026,
author = {Myers, Rebecca and Yildiz, Melek and Nuri Ozbek, Mehmet and Manzoor, Jaida and Ibrahim, Mohsina and Yajnik, Chittaranjan and Atar, Muge and Şiklar, Zeynep and Acar, Sezer and Globa, Evgenia and Magdy Omar, Omneya and Demirbilek, Huseyin and Hassan, Samar and Demir, Korcan and Hanif, Misbah and Guran, Tulay and Hatipoglu, Nihal and Koçyiğit, Cemil and Colclough, Kevin and Houghton, Jayne and Hattersley, Andrew and Van Heugten, Rachel and Patel, Kashyap and Monogenic Diabetes Consortium, Monogenic Diabetes Consortium},
title = {Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {2},
pages = {e362--e367},
doi = {10.1210/clinem/dgaf430}
}
EUVIMED